Medias
Contact :Nathalie VANDENBROUCKE
Adress : 335 rue du Chêne vert
31670 LABÈGE – FRANCE
Phone :+33 531 619 536
Email : contact@dendris.fr
Publications
While the Covid-19 pandemic has shown that infectious diseases represent a major risk, not only for people’s health but also for the economy, the Dendris company has just developed a third generation biochip which aims to facilitate rapid identification of pathogens on an automated platform.
4 years after its creation, Dendris announces the launch of the marketing of its molecular diagnostic solution. The biotechnology start-up based in Labège is developing an in vitro diagnostic kit dedicated to public and private laboratories.
Press release – December 7, 2023
As winter approaches and in the post-COVID context, concern about pandemics is growing more anxiety-provoking. Dendris, a startup based in Labège (31), offers an innovative in vitro diagnostic solution, based on artificial intelligence (AI) and machine learning to massively respond to the challenges of fighting pandemics.
Press release – July 6, 2023
“There is no other in vitro diagnostic device that currently uses artificial intelligence,” explains Mathilde Plinet, data analysis engineer at Dendris in charge of learning the artificial intelligence model. Unlike other approaches based on predefined rules, Dendris has focused on machine learning with the use of an automatic supervised learning algorithm.
Press release – May 11, 2023
“Dendris comes out of the woods” is how Richard Fabre, one of its founders, a Toulouse biologist and creator of the Biopole laboratory, defines the reliable, robust and rapid diagnostic solution developed by the start-up (based in Labège), after several years of research and development. This new generation of diagnostic tools is aimed at health professionals (public and private laboratories), for better patient care by clinicians.
Press release – 3 April 2024
FROM R&D TO INDUSTRY
DENDRIS wishes to raise €1.5 million to accelerate marketing of its solution and its deployment in France and internationally, to continue the development of panels covering all types of samples, finally for comply with the new CE IVDR regulations.